Furukawa and colleagues use cryo-EM, molecular dynamics simulations, and electrophysiology to dissect the binding sites of the clinically important channel blockers phencyclidine, ketamine, and memantine to NMDA receptors, providing a blueprint for improved therapeutics.
- Tsung-Han Chou
- Max Epstein
- Hiro Furukawa
